BZ Trust is open to sale of 16% stake in Roche Holding

Article Abstract:

BZ Trust has expressed interest in selling its minority share of Roche Holding AG. BZ, which will sell its share if an acceptable offer is made, owns 16% of Roche.

BZ Trust Ltd.

---

Roche weighs cost-cutting plan to boost ailing drug division

Article Abstract:

The board of Roche Holding Ltd. is considering an extensive plan for cost reduction for the company's pharmaceutical operations. The plan involves an undecided number of job cuts.

Financial management, Finance

---

King abandons Elan agreement

Article Abstract:

King Pharmaceuticals Inc. has terminated its plan to acquire two of Elan Corp.'s products. King accused of Elan of "various breaches and misrepresentations" in the $850 million (781.2 million euros) bid.

United States, Strategy & planning, Ireland, Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Metabolic Agents NEC, Metabolic Agents, Mergers, acquisitions and divestments, Company acquisition/merger, Elan Corporation PLC, ELN, Company business planning, King Pharmaceuticals Inc.

Similar abstracts:

• Abstracts: KLM launches restructuring plan to boost flagging profitability. Holding pattern: KLM, Alitalia face uncertainty as deal fails
• Abstracts: Moscow prosecutors are seeking to overturn Norilsk privatization. Stillwater's holders clear Norilsk's offer
• Abstracts: Roche sees operating margin shrinking this year (Roche Holding AG). Roche projects drug-sales growth of up to 8% in '01
• Abstracts: GM Europe to engineer basics of midsize cars: German unit Opel to begin auto maker's global shift in developing its vehicles
• Abstracts: Cybersquatting: European companies are not amused by spread of bogus coporate sites. Retailers' ultimate cool tool: the mobile phone

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.